摘要
Development of magnetic resonance imaging (MRI) contrast agents (CAs) is still one of the research hotspots due to the inherent limitations of T-1- or T-2-weighted CAs and T-1/T-2 dual-mode CAs. To dramatically enhance the MRI contrast between tumors and normal tissues, we propose a new concept of contrary contrast-MRI (CC-MRI), whose specific definition is that CC-MRI CAs present a positive or negative signal at normal tissues, but show contrary signals at diseased tissues. To realize CC-MRI of tumors, we designed and developed a tumor microenvironment (TME) dual responsive CA (i.e., SA-FeGdNP-DOX@mPEG), which is almost not responsive under normal physiological conditions, but highly responsive to the acidic and reductive TME. Our SA-FeGdNP-DOX@mPEG shows a negative MRI signal under normal physiological conditions due to the high r(2) value (336.9 mM(-1) s(-1)) and high r(2)/r(1) ratio (18.4), but switches to a positive MRI signal in the TME because of the high r(1) value (20.32 mM(-1) s(-1)) and low r(2)/r(1) ratio (7.2). Our TME dual responsive SA-FeGdNP-DOX@mPEG significantly enhanced the contrast of MR images between tumors and livers, and the Delta SNR difference reached 501%. In addition, our SA-FeGdNP-DOX2@mPEG2 with tumor targetability and controlled DOX release responding to the TME was also used for tumor-specific chemotherapy with reduced side effects.
学科与关键词
- Hofmeister Effect-Based T1-T2 Dual-Mode MRI and Enhanced Synergistic Therapy of TumorChen, Chuyao; Huang, Cong; Liu, Jiamin; Tao, Jia; Chen, Yuying; Deng, Kan; Xu, Yikai*; Lin, Bingquan*; Zhao, Peng*ACS applied materials & interfaces, 2022.被引 2
- Intelligent Pore Switch of Hollow Mesoporous Organosilica Nanoparticles for High Contrast Magnetic Resonance Imaging and Tumor-Specific ChemotherapyHuang, Lin; Feng, Jie; Fan, Wenpei*; Tang, Wei; Rong, Xiaoxiang; Liao, Wangjun; Wei, Zhenni; Xu, Yikai; Wu, Aiguo*; Chen, Xiaoyuan*; Shen, Zheyu*Nano Letters, 2021, 21(22): 9551-9559.被引 29
- Novel Nanosized Gd3+-ALGD-G2-C595: In vivo Dual Selective MUC-1 Positive Tumor Molecular MR Imaging and Therapeutic AgentMehdi Mirzaei; Mohammadali MohagheghiJournal of Nanomedicine & Nanotechnology, 2012, 03(07).
